Mira Pharmaceuticals (MIRA) Invested Capital (2022 - 2025)

Mira Pharmaceuticals has disclosed Invested Capital across 4 years of filings, most recently posting $10.4 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $10.4 million, up 372.78% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.4 million (up 372.78% YoY), and the FY2025 annual result was $10.4 million, up 372.78% from the prior year.
• Invested Capital came in at $10.4 million for Q4 2025 at Mira Pharmaceuticals, up from $7.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $10.4 million in Q4 2025 to a low of -$1.8 million in Q1 2023.
• The 4-year median for Invested Capital is $2.2 million (2024), against an average of $3.0 million.
• Across the five-year window, Invested Capital surged 2432.48% in 2023 and tumbled 74.32% in 2025, its largest moves.
• Mira Pharmaceuticals' Invested Capital stood at -$463170.0 in 2022, then soared by 1044.44% to $4.4 million in 2023, then tumbled by 49.71% to $2.2 million in 2024, then jumped by 372.78% to $10.4 million in 2025.
• The last three Invested Capital figures came in at $10.4 million (Q4 2025), $7.5 million (Q3 2025), and $569859.0 (Q2 2025), per Business Quant data.